Clinical operations field note

The Hidden Cost of a Poor Oncology CRA Fit

Evaluate oncology CRA staffing costs beyond hourly rates, including CTM oversight, unresolved site issues, and repeat monitoring work.

By Lampgen Clinical Research

1 min read · estimated

The Most Expensive CRA
  1. MISSED RISK SIGNALS Small unresolved patterns can become protocol, data, or compliance problems.
  2. WEAK FOLLOW-UP Open items consume site, CRA, CTM, and vendor time repeatedly.
  3. POOR DOCUMENTATION If the report does not explain the risk, oversight becomes harder.
  4. SELECT FOR THE RISK THE PERSON CAN MANAGE, NOT ONLY THE RATE SUBMITTED.

Hourly rate is visible. The cost of weak execution is harder to see.

A CRA who misses patterns, delays escalation, submits unclear reports, or repeatedly reopens the same site issues creates work for the CTM, sponsor, site, and vendors.

That cost can appear as:

• additional review cycles • unresolved action items • preventable deviations • delayed data cleaning • retraining • turnover during execution

Rate matters. So do protocol complexity, therapeutic relevance, judgment, communication, and documentation quality.

Contractor selection should reflect the operational risk the person will be expected to manage.

AVAILABLE FOR NEW PARTNERSHIPS

What does your clinical team need next?